Prevalence of psychoactive drugs in injured patients presenting to an emergency department.
bias
injury
prevalence
psychoactive drug
Journal
Emergency medicine Australasia : EMA
ISSN: 1742-6723
Titre abrégé: Emerg Med Australas
Pays: Australia
ID NLM: 101199824
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
09
06
2022
received:
09
01
2022
accepted:
12
06
2022
pubmed:
21
7
2022
medline:
19
1
2023
entrez:
20
7
2022
Statut:
ppublish
Résumé
The aim of the present study was to obtain an unbiased understanding of the prevalence of psychoactive drugs in trauma patients presenting to a large ED. Consecutive adult patients presenting to the ED with an injury resulting in a trauma call had an anonymised, additional blood test taken for detection of over 2000 drugs. Laboratory testing was to judicial standards. Drugs given by ambulance pre-hospital were detected but excluded from the analysis. Over 6 months 276 (74.7%) of 371 patients were tested. Of the 276 patients tested, 158 (57.2%) had one or more psychoactive drug present. Recreational drugs were detected in 101 (36.6%) patients and medicinal drugs in 88 (31.8%) patients, with a combination of both detected in 31 (11.2%) patients. The most common drugs detected were cannabis (22.1%), antidepressants (18.4%), alcohol (15.5%), opioids (10.1%), benzodiazepine/z-drugs (9.4%) and methamphetamine (7.2%). The prevalence of psychoactive drugs differed by age group, sex and cause of injury. The prevalence of psychoactive drugs in injury presentations to an ED is high, and provides an opportunity to reduce harm. The present study demonstrates the feasibility of an approach which limits bias and obtains results that accurately reflect the drug prevalence in injured cohorts. Systematic testing of injured patients is an important contribution to the epidemiology of injury.
Identifiants
pubmed: 35859101
doi: 10.1111/1742-6723.14040
doi:
Substances chimiques
Illicit Drugs
0
Psychotropic Drugs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
25-33Informations de copyright
© 2022 Australasian College for Emergency Medicine.
Références
Cherpitel CJ. Alcohol and injuries: a review of international emergency room studies since 1995. Drug Alcohol Rev. 2007; 26: 201-14.
Riuttanen A, Jäntti SJ, Mattila VM. Alcohol use in severely injured trauma patients. Sci. Rep. 2020; 10: 17891.
Rossow I, Bogstrand ST, Ekeberg Ø, Normann PT. Associations between heavy episodic drinking and alcohol related injuries: a case control study. BMC Public Health 2013; 13: 1076.
New Zealand Transport Agency. Risks of Driving When Affected by Cannabis, MDMA (Ecstasy) and Methamphetamine and the Deterrence of Such Behaviour: A Literature Review. 2020. [Cited 4 Nov 2021.] Available from URL: https://www.nzta.govt.nz/resources/research/reports/664
Bernhoft IM, Hels T, Lyckegaard A, Houwing S, Verstraete AG. Prevalence and risk of injury in Europe by driving with alcohol, illicit drugs and medicines. Procedia. Soc. Behav. Sci. 2012; 48: 2907-16.
Mathijssen R, Houwing S. The Prevalence and Relative Risk of Drink and Drug Driving in the Netherlands: A Case-Control Study in the Tilburg Police District. 2005. [Cited 4 Nov 2021.] Available from URL: https://www.swov.nl/sites/default/files/publicaties/rapport/r-2005-09.pdf
Zeisser C, Stockwell TR, Chikritzhs T, Cherpitel C, Ye Y, Gardner C. A systematic review and meta-analysis of alcohol consumption and injury risk as a function of study design and recall period. Alcohol. Clin. Exp. Res. 2013; 37: E1-8.
Roche AM, Chapman J, Duraisingam V, Phillips B, Finnane J, Pidd K. Flying below the radar: psychoactive drug use among young male construction workers in Sydney, Australia. Subst. Use Misuse 2021; 56: 758-67.
Vitale S, van de Mheen D. Illicit drug use and injuries: a review of emergency room studies. Drug Alcohol Depend. 2006; 82: 1-9.
Wilson T, Wisborg T, Vindenes V, Jamt RG, Furuhaugen H, Bogstrand ST. Psychoactive substances have major impact on injuries in rural arctic Norway - a prospective observational study. Acta Anaesthesiol. Scand. 2021; 65: 824-33.
Gjerde H, Normann PT, Pettersen BS et al. Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. Accid. Anal. Prev. 2008; 40: 1765-72.
Furuhaugen H, Jamt REG, Nilsson G, Vindenes V, Gjerde H. Roadside survey of alcohol and drug use among Norwegian drivers in 2016-2017: a follow-up of the 2008-2009 survey. Traffic Inj. Prev. 2018; 19: 555-62.
Ahlm K, Björnstig U, Öström M. Alcohol and drugs in fatally and non-fatally injured motor vehicle drivers in northern Sweden. Accid. Anal. Prev. 2009; 41: 129-36.
Schumann J, Perkins M, Dietze P et al. The prevalence of alcohol and other drugs in fatal road crashes in Victoria, Australia. Accid. Anal. Prev. 2021; 153: 105905.
Legrand S-A, Gjerde H, Isalberti C et al. Prevalence of alcohol, illicit drugs and psychoactive medicines in killed drivers in four European countries. Int. J. Inj. Contr. Saf. Promot. 2014; 21: 17-28.
Poulsen H, Moar R, Pirie R. The culpability of drivers killed in New Zealand road crashes and their use of alcohol and other drugs. Accid. Anal. Prev. 2014; 67: 119-28.
New Zealand Police. National Wastewater Testing Programme Results, Quarter 1, 2020. [Cited 17 Nov 2021.] Available from URL: https://www.police.govt.nz/about-us/publication/national-wastewater-testing-programme-quarter-1-2020
Immunalysis. IMMUNALYSIS Cannabinoids (THCA/CTHC) Direct ELISA Kit 205-0192. [Cited 17 Nov 2021.] Available from URL: https://immunalysis.com/products/elisa/elisa-for-forensic/
Raikos N, Schmid H, Nussbaumer S et al. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis. Forensic Sci. Int. 2014; 243: 130-6.
Vaiano F, Busardò FP, Palumbo D et al. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases. J. Pharm. Biomed. Anal. 2016; 129: 441-9.
Hess C, Murach J, Krueger L et al. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples: detection of 93 synthetic cannabinoids and retrospective analysis. Drug Test. Anal. 2017; 9: 721-33.
Ong RS, Kappatos DC, Russell SGG et al. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - a New Zealand perspective of use in 2018. Drug Test. Anal. 2020; 12: 195-214.
Heath and Disability Commissioner. Code of Health and Disability Services Consumers Rights. 1996. Available from URL: https://www.hdc.org.nz/your-rights/about-the-code/code-of-health-and-disability-services-consumers-rights/
Thomas FD, Berning A, Darrah J et al. Drug and Alcohol Prevalence in Seriously and Fatally Injured Road Users before and during the COVID-19 Public Health Emergency. 2020. [Cited 4 Nov 2021.] Available from URL: https://rosap.ntl.bts.gov/view/dot/50941
Bakke E, Bogstrand ST, Normann PT, Ekeberg Ø, Bachs L. Influence of alcohol and other substances of abuse at the time of injury among patients in a Norwegian emergency department. BMC Emerg. Med. 2016; 16: 20.
Legrand S-A, Silverans P, de Paepe P, Buylaert W, Verstraete AG. Presence of psychoactive substances in injured Belgian drivers. Traffic Inj. Prev. 2013; 14: 461-8.
Brubacher JR, Chan H, Martz W et al. Prevalence of alcohol and drug use in injured British Columbia drivers. BMJ Open 2016; 6: e009278.
Gjerde H, Sousa TR, De Boni R et al. A comparison of alcohol and drug use by random motor vehicle drivers in Brazil and Norway. Int. J. Drug Policy 2014; 25: 393-400.
Gamboa D, Jørgenrud B, Bryun EA et al. Prevalence of psychoactive substance use among acutely hospitalised patients in Oslo and Moscow: a cross-sectional, observational study. BMJ Open 2020; 10: e032572.
Centers for Disease Control and Prevention. Annual Surveillance Report of Drug-Related Risks and Outcomes - United States. Surveillance Special Report. 2018. [Cited 4 Nov 2021.] Available from URL: https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-report.pdf
Hill LL, Lauzon VL, Winbrock EL, Li G, Chihuri S, Lee KC. Depression, antidepressants and driving safety. Inj. Epidemiol. 2017; 4: 10.
Vindenes V, Lund HME, Andresen W et al. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci. Int. 2012; 219: 165-71.
Australasian College for Emergency Medicine. Alcohol and Methamphetamine Harm in Emergency Departments: Findings from the 2019 Snapshot Survey. 2020. [Cited 4 Nov 2021.] Available from URL: https://acem.org.au/getmedia/f7bec2c4-6573-471f-8cf4-f9a0bc466506/Alcohol-Snapshot-Report_R6